Tag: rilonacept

22-HVI-3073724 CQD 650×450
August 19, 2022/Clinical Cardiology

Recurrent Pericarditis: It’s Time to Recognize the Paradigm Shift in Imaging and Therapeutics

Targeted IL-1 blockers and CMR techniques allow more-tailored treatment strategies

20-HVI-2006252-pericarditis-650×450
November 17, 2020/Research

RHAPSODY Trial Reveals Unprecedented Reduction of Recurrent Pericarditis With Rilonacept

Phase 3 study may lead to first FDA approval for the indication

19-HRT-6045-pericarditis-650×450
December 19, 2019/Research

Evidence Mounts in Support of IL-1 Inhibition for Recurrent Pericarditis

Anakinra and rilonacept show dramatic reductions in recurrence rates

BackPage 1 of 1Next
Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

Ad